Add BrightSurf on Google Email

NIH/National Institute on Drug Abuse


Buprenorphine misuse decreased among U.S. adults with opioid use disorder from 2015-2019

A study published in JAMA Network Open found that nearly three-fourths of U.S. adults with buprenorphine use did not misuse the medication in 2019, trending downward between 2015-2019 despite increased treatment. The research highlights the need to expand access to proven treatment approaches like buprenorphine therapy to reduce misuse.

SourceNIH/National Institute on Drug Abuse·JournalJAMA Network Open·DateOct 15, 2021

The Hidden US COVID-19 Pandemic: Orphaned children – more than 140,000 US children lost a primary or secondary caregiver due to the COVID-19 pandemic

A new study reveals that more than 140,000 US children under age 18 lost a primary or secondary caregiver due to the COVID-19 pandemic. The study shows racial and ethnic disparities in caregiver deaths, with children of minorities accounting for 65% of those who lost a primary caregiver.

Methamphetamine-involved overdose deaths nearly tripled between 2015 to 2019, NIH study finds

Overdose deaths involving methamphetamine rose 180% from 2015 to 2019, outpacing increases in methamphetamine use. Riskier patterns of use, including frequent use and co-use with other substances, contributed to the surge. Diverse populations, particularly American Indians/Alaska Natives and young adults, are disproportionately affected.

SourceNIH/National Institute on Drug Abuse·JournalJAMA Psychiatry·DateSep 22, 2021

Disparities in opioid overdose deaths continue to worsen for Black people, study suggests

A recent NIH-supported study highlights alarming disparities in opioid overdose deaths among non-Hispanic Black individuals in the US. The rates increased by 38% from 2018 to 2019, with Kentucky and Ohio experiencing the largest increases. The research emphasizes the need for community-based interventions addressing these disparities.

SourceNIH/National Institute on Drug Abuse·JournalAmerican Journal of Public Health·TypeData/statistical analysis·DateSep 9, 2021

NIH-funded study finds overall rate of drug use among 10-14 year-olds remained stable during the 2020 COVID-19 pandemic

A recent NIH-funded study found that the overall rate of drug use among 10-14 year-olds remained stable during the 2020 COVID-19 pandemic, with adolescents experiencing stress and hardship being most likely to use substances. The study also detected shifts in substance types, with alcohol use declining and nicotine use increasing.

SourceNIH/National Institute on Drug Abuse·JournalJournal of Adolescent Health·TypeData/statistical analysis·DateAug 24, 2021

More than 1.5M children lost a primary or secondary caregiver due to the COVID-19 pandemic

A study published in The Lancet estimates that over 1.5 million children worldwide have lost a parent, custodial grandparent, or other older relative due to COVID-19-related deaths. This phenomenon, known as orphanhood, has severe and long-lasting consequences for children's mental health and wellbeing. To address this issue, evidence-...

Long-lasting medications may improve treatment satisfaction for opioid use disorder

A new study published in JAMA Network Open suggests that extended-release formulations of buprenorphine may improve treatment satisfaction for patients with opioid use disorder. The study found that the extended-release injection was well-tolerated and produced more positive patient-reported outcomes compared to daily oral buprenorphine.

SourceNIH/National Institute on Drug Abuse·JournalJAMA Network Open·DateMay 10, 2021

Younger age of first drug use associated with faster development of substance use disorder

A study by NIH/NIDA found that adolescents who started using cannabis or misusing prescription drugs earlier are more likely to develop substance use disorders. The prevalence of substance use disorders was higher among adolescents than young adults at various time frames since first drug use, highlighting the vulnerability of young pe...

SourceNIH/National Institute on Drug Abuse·JournalJAMA Pediatrics·DateMar 29, 2021

Combination treatment for methamphetamine use disorder shows promise in NIH study

A combination of injectable naltrexone and oral bupropion was found to be effective in treating adults with moderate or severe methamphetamine use disorder. Participants responded at a significantly higher rate to the treatment, with an NNT of 9, indicating its potential as a promising addition to current approaches.

SourceNIH/National Institute on Drug Abuse·JournalNew England Journal of Medicine·DateJan 13, 2021